Danish Pharmacovigilance Update, 17 March 2011

In this issue of Danish Pharmacovigilance Update:

• Reports of serious side effects in Japan from the childhood vaccines Prevenar (PCV7)® and Act-Hib®
• Reports of serious side effects in France from the childhood vaccine Prevenar13®
• Indication for Zerit® (stavudine) restricted due to potentially serious side effects
• Rotarix and RotaTeq® and risk of intussusception
• Tygacil® (tigecycline) and increased mortality in clinical studies
• Thalidomide Celgene (thalidomide) and risk of myocardial infarction and thromboembolic events
• New recommendations for use of Brinavess®
• The Danish Medicines Agency has received a report of a death in connection with treatment with Concerta® (methylphenidate) for the treatment of ADHD
• Antidepressants (SSRIs) and deaths or serious side effects in newborns
• Consumption and side effects from the weight-loss product Regenon®

Download the newsletter in the factbox to the right.